David Bouchey
Stock Analyst at Aegis Capital
(n/a)
# 4,406
Out of 4,412 analysts
6
Total ratings
n/a
Success rate
-60.17%
Average return
Main Sectors:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Initiates: Buy | $260 | $0.95 | +27,268.42% | 1 | Aug 7, 2023 | |
| STSS Sharps Technology | Initiates: Buy | $16 | $0.29 | +5,512.07% | 1 | May 9, 2023 | |
| ATXI Avenue Therapeutics | Initiates: Buy | $32 | $6.20 | +416.13% | 1 | Apr 3, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $1.89 | +587.83% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | n/a | $1.46 | - | 2 | Oct 19, 2018 |
Sunshine Biopharma
Aug 7, 2023
Initiates: Buy
Price Target: $260
Current: $0.95
Upside: +27,268.42%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $16
Current: $0.29
Upside: +5,512.07%
Avenue Therapeutics
Apr 3, 2023
Initiates: Buy
Price Target: $32
Current: $6.20
Upside: +416.13%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $1.89
Upside: +587.83%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: n/a
Current: $1.46
Upside: -